Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Bioorg Med Chem Lett. 2014 May 28;24(15):3493–3498. doi: 10.1016/j.bmcl.2014.05.062

Figure 2.

Figure 2

New 5,6-fused bicyclic heteroaromatic scaffold analogs (7–12) prepared to evaluate the effects of scaffold switching on anti-TB activity. The moving, incorporating or removing nitrogen(s) within the 5,6-fused bicyclic framework from that of the imidazo[1,2-a]pyridine are denoted in red.